Tilray CEO: Opportunities in clinical cannabis are substantial
Tilray’s stock is up as of late, nonetheless level-headed down 80 percent from a February high. CNBC’s Frank Holland reports on his dialog with Tilray CEO Irwin Simon about the…
Ohio Clinical Marijuana CEO Suspended for Giving out Product samples | Hashish Legalization News
Ohio Clinical Marijuana CEO Suspended for Giving out Product samples | Hashish Legalization News #cannabis #legalization #news 🌱 We can support with your cannabis industry. Salvage in contact here! p🔔…